Clinical Trials Directory

Trials / Completed

CompletedNCT03837223

RESCUE PROTOCOL AND FRESH EMBRYO TRANSFER

RESCUE PROTOCOL AND FRESH EMBRYO TRANSFER AFTER TRIGGER WITH ANALOGS OF GNRH: THE HUMANITAS PROTOCOL

Status
Completed
Phase
Study type
Observational
Enrollment
271 (actual)
Sponsor
Istituto Clinico Humanitas · Academic / Other
Sex
Female
Age
18 Years – 38 Years
Healthy volunteers
Not accepted

Summary

Ovarian Hyperstimulation Syndrome (OHSS) is one of the most dangerous complications of Assisted Reproductive Technologies (ART) cycles. The use in clinical practice of the GnRH antagonist has made it possible to perform the trigger with GnRH analogues reducing the risk of OHSS. The trigger with analogue increases the Abortion Rate (AR) and reduces the Ongoing Pregnancy Rate (OPR), because the luteal phase in these cycles is particularly deficient. To reduce this occurrence several studies have focused on the importance of support of the luteal phase. The aims of study is to evaluate OPR and AR in patients at intermediate risk of OHSS (\<18 recovered oocytes) which performed GnRH trigger and rescue protocol.

Conditions

Interventions

TypeNameDescription
DRUGGnRH agonistIn High Responder patients (HR) (more than 18 follicles with diameter ≥ 12mm at ovulation induction), the trigger was obtained with triptorelin 0.2 mg sc. In this cohort if less of 18 oocytes were retrieved, patients were considered at intermediate risk of OHSS and fresh transfer was performed. An adequate support of the luteal phase was initiated: HCG 1500 IU / sc the day of the pick up + estradiol 4 mg + vaginal progesterone 400 mg daily (Rescue protocol).

Timeline

Start date
2013-03-01
Primary completion
2016-12-31
Completion
2016-12-31
First posted
2019-02-12
Last updated
2019-02-12

Source: ClinicalTrials.gov record NCT03837223. Inclusion in this directory is not an endorsement.